Insmed (INSM) Interest & Investment Income (2010 - 2026)

Insmed has reported Interest & Investment Income for 17 years, with the latest figure at $11.0 million in Q2 2026.

• On a quarterly basis, Interest & Investment Income fell 16.98% year-over-year to $11.0 million in Q2 2026; TTM through Jun 2026 was $56.5 million, a 7.86% decrease from a year earlier, with the FY2025 full-year figure at $60.7 million, up 13.79% from the prior year.
• Interest & Investment Income was $11.0 million for Q2 2026 at Insmed, down from $12.0 million in the prior quarter.
• The five-year high for Interest & Investment Income was $18.3 million in Q3 2025, with the low at $137000.0 in Q1 2022.
• Average Interest & Investment Income over 5 years is $10.6 million, with a median of $10.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Interest & Investment Income jumped 13536.07% in 2022, then decreased 16.98% in 2026.
• Over 5 years, Interest & Investment Income stood at $8.3 million in 2022, then advanced by 18.45% to $9.9 million in 2023, then soared by 75.14% to $17.3 million in 2024, then slipped by 11.71% to $15.2 million in 2025, then retreated by 27.94% to $11.0 million in 2026.
• The last three Interest & Investment Income figures came in at $11.0 million (Q2 2026), $12.0 million (Q1 2026), and $15.2 million (Q4 2025), per Business Quant data.